EIF3H and neoplasm: Somewhat surprising, the expression of EIF3S3 was not higher in the hormone-refractory compared to the untreated tumours, despite the fact that hormone-refractory tumours, in general, contain higher frequency of 8q gain (Visakorpi et al, 1995).